Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citramel inhalation crossover study in cystic fibrosis
ACTRN12615000654550Phase 2Completed
- Sponsor
- Breathe Easy
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Citramel in cystic fibrosis (CF) (2 arms), sponsored by Breathe Easy. Primary endpoint: Safety. Started Jun 2016; status: completed.
02
Drugs
Citramel
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12615000654550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000654550.